Vimarsana
Biggest News Aggregation in the World

Murray Stewart News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Murray Stewart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Murray Stewart Today - Breaking & Trending Today

Charity Spotlight: Musical fundraiser to drum up vital funds in fight against brain tumours - Vimarsana News

Charity Spotlight: Musical fundraiser to drum up vital funds in fight against brain tumours

A student-led DJ collective that founded, designed, and coordinated a full-scale electronic music festival, art exhibition, and fundraising event last year is to host another event next month.

Couple forced to cancel holiday after 'total chaos' at airport sees them miss flight - Vimarsana News

Couple forced to cancel holiday after 'total chaos' at airport sees them miss flight

Sue and Murray Stewart made it to Bristol Airport in plenty of time for their easyJet flight to Croatia, but a series of delays and "total chaos" meant they missed their flight

Q3 2023 EPS Estimates for X4 Pharmaceuticals, Inc. Lifted by Analyst (NASDAQ:XFOR) - Vimarsana News

Q3 2023 EPS Estimates for X4 Pharmaceuticals, Inc. Lifted by Analyst (NASDAQ:XFOR)

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR – Free Report) – Analysts at Zacks Small Cap boosted their Q3 2023 earnings per share (EPS) estimates for shares of X4 Pharmaceuticals in a research note issued to investors on Tuesday, August 15th. Zacks Small Cap analyst D. Bautz now expects that the company will post earnings per share of […]

Source: wkrb13.com
X4 Pharmaceuticals (NASDAQ:XFOR) Announces Earnings Results - Vimarsana News

X4 Pharmaceuticals (NASDAQ:XFOR) Announces Earnings Results

X4 Pharmaceuticals (NASDAQ:XFOR – Get Free Report) issued its earnings results on Thursday. The company reported ($0.33) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.16), MarketWatch Earnings reports. During the same quarter last year, the company earned ($0.60) earnings per share. X4 Pharmaceuticals Price Performance Shares of XFOR stock […]

HC Wainwright Reiterates "Buy" Rating for X4 Pharmaceuticals (NASDAQ:XFOR) - Vimarsana News

HC Wainwright Reiterates "Buy" Rating for X4 Pharmaceuticals (NASDAQ:XFOR)

HC Wainwright restated their buy rating on shares of X4 Pharmaceuticals (NASDAQ:XFOR – Free Report) in a research note issued to investors on Friday, Benzinga reports. The firm currently has a $3.00 price target on the stock. Separately, Stifel Nicolaus boosted their price objective on shares of X4 Pharmaceuticals from $4.00 to $5.00 in a […]